Table 2.
Comorbidities and HIV Care and Treatment Variables
| Patients on ART with all cardiovascular disease risk data available (n=1496) |
|
|---|---|
| Median (IQR) body mass index | 22.3 (20.3 – 24.6) |
| Body mass index | |
| <18.5 | 139 (9.3%) |
| 18.5 – 25 | 952 (63.6%) |
| 25 – 30 | 266 (17.8%) |
| >30 | 48 (3.2%) |
| Unknown | 91 (6.1%) |
| Median (IQR) blood pressure, mmHg | 128 (116 – 139) / 79 (70 – 85) |
| Hypertension (systolic >140 mmHg) | 304 (20.3%) |
| Diabetes mellitus (fasting ≥7mmol/L) | 124 (8.3%) |
| Median (IQR) total cholesterol, mmol/L | 5.1 (4.4 – 5.8) |
| Total cholesterol (>6.2 mmol/L) | 686 (45.9%) |
| Median (IQR) HDL cholesterol, mmol/L | 1.2 (1.0 – 1.5) |
| HDL cholesterol (<1 mmol/L) | 322 (21.5%) |
| Median (IQR) triglycerides, mmol/L | 1.7 (1.1 – 2.6) |
| Triglycerides (>2.26 mmol/L) | 584 (39.0%) |
| HBV co-infection | |
| Positive | 130 (8.7%) |
| Negative | 1168 (78.1%) |
| Not tested | 198 (13.2%) |
| HCV co-infection | |
| Positive | 83 (5.5%) |
| Negative | 1178 (78.7%) |
| Not tested | 235 (15.7%) |
| Median (IQR) CD4 cell count, cells/mm3 | 460 (336 – 616) |
| CD4 count, cells/mm3 | |
| <200 | 85 (5.7%) |
| ≥200 | 1149 (76.8%) |
| Unknown | 262 (17.5%) |
| Viral load, copies/mL | |
| ≥400 | 46 (3.1%) |
| <400 | 998 (66.7%) |
| Unknown | 452 (30.2%) |
| Prior AIDS diagnosis | |
| Yes | 721 (48.2%) |
| None known | 775 (51.8%) |
| Current indinavir use | |
| Yes | 18 (1.2%) |
| No | 1478 (98.8%) |
| Current lopinavir use | |
| Yes | 190 (12.7%) |
| No | 1306 (87.3%) |
| Current abacavir use | |
| Yes | 213 (14.2%) |
| No | 1283 (85.8%) |
| Median (IQR) time since ART initiation, years | 6.0 (3.2 – 9.9) |
| Time since ART initiation, years | |
| <2 | 140 (9.4%) |
| 2 – 4 | 413 (27.6%) |
| 4 – 8 | 366 (24.5%) |
| >8 | 577 (38.6%) |
| Year of smoking assessment | |
| Before 2011 | 43 (2.9%) |
| 2011 | 165 (11.0%) |
| 2012 | 690 (46.1%) |
| 2013 | 598 (40.0%) |
| Smoking status | |
| Current | 298 (19.9%) |
| Former | 337 (22.5%) |
| Never | 861 (57.6%) |
ART, antiretroviral therapy; IQR, interquartile range; MI, myocardial infarction; TAHOD, TREAT Asia HIV Observational Database